Personal tools

MCL coexpression mm9:901: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002113!1.54e-19!14;UBERON:0003918!1.54e-19!14;UBERON:0011143!1.54e-19!14;UBERON:0005095!1.54e-19!14;UBERON:0007687!1.54e-19!14;UBERON:0006554!1.83e-14!18;UBERON:0001008!1.57e-13!19;UBERON:0000489!6.17e-12!21;UBERON:0003135!1.71e-10!15;UBERON:0003101!1.07e-09!16;UBERON:0000079!1.07e-09!16;UBERON:0000473!6.14e-09!14;UBERON:0000991!3.10e-08!18;UBERON:0005564!3.10e-08!18;UBERON:0003133!4.13e-07!24;UBERON:0004176!4.82e-07!17;UBERON:0009196!4.82e-07!17;UBERON:0009117!4.82e-07!17;UBERON:0001301!9.96e-07!3;UBERON:0006555!9.96e-07!3;UBERON:0005103!9.96e-07!3;UBERON:0000083!9.96e-07!3;UBERON:0009201!9.96e-07!3;UBERON:0004819!9.96e-07!3;UBERON:0006553!9.96e-07!3;UBERON:0003074!9.96e-07!3;UBERON:0003060!9.96e-07!3
|ontology_enrichment_uberon=UBERON:0002113!1.54e-19!14;UBERON:0003918!1.54e-19!14;UBERON:0011143!1.54e-19!14;UBERON:0005095!1.54e-19!14;UBERON:0007687!1.54e-19!14;UBERON:0006554!1.83e-14!18;UBERON:0001008!1.57e-13!19;UBERON:0000489!6.17e-12!21;UBERON:0003135!1.71e-10!15;UBERON:0003101!1.07e-09!16;UBERON:0000079!1.07e-09!16;UBERON:0000473!6.14e-09!14;UBERON:0000991!3.10e-08!18;UBERON:0005564!3.10e-08!18;UBERON:0003133!4.13e-07!24;UBERON:0004176!4.82e-07!17;UBERON:0009196!4.82e-07!17;UBERON:0009117!4.82e-07!17;UBERON:0001301!9.96e-07!3;UBERON:0006555!9.96e-07!3;UBERON:0005103!9.96e-07!3;UBERON:0000083!9.96e-07!3;UBERON:0009201!9.96e-07!3;UBERON:0004819!9.96e-07!3;UBERON:0006553!9.96e-07!3;UBERON:0003074!9.96e-07!3;UBERON:0003060!9.96e-07!3
|tfbs_overrepresentation_for_novel_motifs=0.393008,0.121181,0.367606,0.434198,0.720982,0.448401,0.538088,0.515265,0.181564,0.0447303,0.494602,0.526159,0.173454,0.550255,1.38589,0,0.742571,1.30041,0.483643,0.620214,0.332107,0.0622758,0.549359,0.258745,0.374936,1.41403,0.153291,0.469052,0.303071,0.757024,0.455168,1.96654,0.250677,0.425071,0.757987,0.60397,0.242032,0.522578,0.221921,0.195877,0.712303,0.460258,0.784847,0.27776,0.209497,0.423266,0.662995,0.484612,0.170971,0.305876,0.725127,0.604356,0.362495,0.985264,1.00271,0.557354,0.314394,0.513517,0.877107,0.555328,0.823643,0.613749,0.192045,0.713876,0.568415,0.754324,1.139,1.48833,0.818971,1.34113,0.922232,1.60452,0.0665967,1.03623,0.433216,0.409836,0.136938,0.651651,0.806481,0.336166,0.179489,0.759925,0.612313,0.968721,0.920903,0.025519,2.70874,4.70749,0.667883,1.65055,1.20871,0.925879,0.856465,1.34857,0.218233,0.202284,0.982739,0.859272,0.663249,0.332938,0.679141,0.843387,0.967837,0.725721,0.724668,0.459825,0.784351,1.20804,0.340849,0.333829,0.386136,0.96962,0.337254,0.499714,1.21576,0.254749,0.0359654,0.437894,0.743872,0.670977,1.04163,0.692953,0.579418,0.650748,1.26989,0.810177,0.546178,0.849691,1.13749,0.268537,0.950857,1.09252,1.10792,0.570914,1.23736,0.829188,0.401212,0.461647,1.18819,2.01886,1.6187,1.14372,0.591394,0.854131,0.718197,0.460705,0.666107,1.9792,0.403515,0.724779,0.766041,0.203102,0.986833,0.598134,0.569994,1.06851,0.605358,0.287226,0.39061,0.400939,1.1977,0.920047,0.810622,0.383936,0.714896,0.562634,0.240994,0.524587,0.331912
}}
}}

Revision as of 19:05, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr11:34108085..34108092,-p1@Foxi1
Mm9::chr11:96156719..96156721,-p@chr11:96156719..96156721
-
Mm9::chr2:74975548..74975563,-p1@ENSMUST00000143898
Mm9::chr7:81210431..81210442,-p@chr7:81210431..81210442
-
Mm9::chr7:86741445..86741455,-p@chr7:86741445..86741455
-
Mm9::chr7:86741570..86741584,-p@chr7:86741570..86741584
-
Mm9::chr7:86741766..86741778,-p@chr7:86741766..86741778
-
Mm9::chr7:86762435..86762451,-p1@Rhcg


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0015696ammonium transport0.0140239391447833
GO:0008519ammonium transmembrane transporter activity0.0140239391447833
GO:0015695organic cation transport0.0140239391447833
GO:0015101organic cation transmembrane transporter activity0.0157760670721659



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
kidney1.54e-1914
kidney mesenchyme1.54e-1914
upper urinary tract1.54e-1914
kidney rudiment1.54e-1914
kidney field1.54e-1914
urinary system structure1.83e-1418
renal system1.57e-1319
cavitated compound organ6.17e-1221
male reproductive organ1.71e-1015
male organism1.07e-0916
male reproductive system1.07e-0916
testis6.14e-0914
gonad3.10e-0818
gonad primordium3.10e-0818
reproductive organ4.13e-0724
external genitalia4.82e-0717
indifferent external genitalia4.82e-0717
indifferent gonad4.82e-0717
epididymis9.96e-073
excretory tube9.96e-073
mesonephric epithelium9.96e-073
mesonephric tubule9.96e-073
nephric duct9.96e-073
kidney epithelium9.96e-073
renal duct9.96e-073
mesonephric duct9.96e-073
pronephric duct9.96e-073


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}